RISK-FACTORS AND HIV SEROPOSITIVITY AMONG INJECTING DRUG-USERS IN BANGKOK

被引:92
|
作者
CHOOPANYA, K
VANICHSENI, S
JARLAIS, DCD
PLANGSRINGARM, K
SONCHAI, W
CARBALLO, M
FRIEDMANN, P
FRIEDMAN, SR
机构
[1] BETH ISRAEL MED CTR,NARCOT & DRUG RES INST,11 BEACH ST,NEW YORK,NY 10013
[2] BANGKOK METROPOLITAN ADM,DEPT HLTH,BANGKOK,THAILAND
[3] WHO,PROGRAM SUBSTANCE ABUSE,CH-1211 GENEVA 27,SWITZERLAND
关键词
DRUG USE; AIDS; HIV; BANGKOK; INJECTING; THAILAND;
D O I
10.1097/00002030-199112000-00014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bangkok experienced an extremely rapid spread of HIV infection among drug injectors in 1987 and 1988. This study examines risk factors for HIV infection and deliberate risk-reduction efforts by drug injectors. Two subsamples of injecting drug users were recruited in November 1989, a group in drug-use treatment (n = 342) and a group new to the treatment system (n = 259). Subjects were interviewed about AIDS risk behavior, and a blood sample was collected for HIV testing. Seroprevalence was 39 and 27% in the in-treatment sample and the new-to-treatment sample, respectively. The in-treatment sample seroprevalence rate is similar to rates observed 6 and 12 months earlier. Three factors were independently associated with HIV infection: subsample, having been in prison, and sharing injection equipment with two or more individuals in the previous 6 months. Deliberate risk reduction was reported by 92% of individuals, with 59% reporting that they had stopped sharing injection equipment. It appears that large-scale risk reduction has greatly slowed HIV transmission among drug injectors in Bangkok.
引用
收藏
页码:1509 / 1513
页数:5
相关论文
共 50 条
  • [1] HIV RISK-FACTORS AMONG INJECTING DRUG-USERS IN 5 US CITIES
    BATTJES, RJ
    PICKENS, RW
    HAVERKOS, HW
    SLOBODA, Z
    AIDS, 1994, 8 (05) : 681 - 687
  • [2] FACTORS ASSOCIATED WITH HIV SEROPOSITIVITY IN EUROPEAN INJECTING DRUG-USERS
    RICHARDSON, C
    ANCELLEPARK, R
    PAPAEVANGELOU, G
    AIDS, 1993, 7 (11) : 1485 - 1491
  • [3] HIV RISK BEHAVIOR AMONG INJECTING DRUG-USERS IN WARSAW
    STARK, K
    SIEROSLAWSKI, J
    WIRTH, D
    GODWODSIKORSKA, C
    MULLER, R
    BIENZLE, U
    AIDS, 1995, 9 (02) : 211 - 213
  • [4] SEXUAL PRACTICES, SEXUALLY-TRANSMITTED DISEASES AND OTHER RISK-FACTORS FOR HIV AMONG INJECTING DRUG-USERS
    CHETWYND, J
    CHAMBERS, A
    HUGHES, A
    AUSTRALIAN JOURNAL OF PUBLIC HEALTH, 1993, 17 (01): : 32 - 35
  • [5] RISK-FACTORS FOR HTLV-II SEROCONVERSION AMONG INJECTING DRUG-USERS IN BALTIMORE
    VLAHOV, D
    KHABBAZ, R
    COHN, S
    GALAI, N
    TAYLOR, E
    KAPLAN, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 448 - 448
  • [6] SEOUL HANTAVIRUS SEROPOSITIVITY AMONG INJECTING DRUG-USERS IN BALTIMORE
    KHABBAZ, RF
    KSIAZEK, TG
    CAIAFFA, WT
    ROLLIN, PE
    TAYLOR, E
    VLAHOV, D
    JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06): : 1636 - 1637
  • [7] HIV RISK AMONG WOMEN INJECTING DRUG-USERS WHO ARE IN JAIL
    MAGURA, S
    KANG, SY
    SHAPIRO, J
    ODAY, J
    ADDICTION, 1993, 88 (10) : 1351 - 1360
  • [8] CHANGES IN HIV RISK BEHAVIORS AMONG COUNSELED INJECTING DRUG-USERS
    MANDELL, W
    VLAHOV, D
    LATKIN, CA
    CARRAN, D
    OZIEMKOWSKA, MJ
    REEDT, L
    JOURNAL OF DRUG ISSUES, 1994, 24 (03) : 555 - 567
  • [9] RISK BEHAVIOR AND HTLV-1 SEROPOSITIVITY IN INJECTING DRUG-USERS
    REZZA, G
    LAZZARIN, A
    UBERTIFOPPA, C
    TUMBARELLO, M
    MENNITIIPPOLITO, F
    PEZZOTTI, P
    TITTI, F
    VERANI, P
    BRITISH JOURNAL OF ADDICTION, 1990, 85 (05): : 686 - 687
  • [10] HIV TESTING AMONG INJECTING DRUG-USERS IN GLASGOW
    COVELL, R
    FOLLETT, E
    COOTE, I
    BLOOR, M
    FINLAY, A
    FRISCHER, M
    GOLDBERG, D
    GREEN, S
    HAW, S
    MCKEGANEY, N
    JOURNAL OF INFECTION, 1993, 26 (01) : 27 - 31